Endoplasmic Reticulum Targeting Ratiometric Fluorescent Probe for Carboxylesterase 2 Detection in Drug-Induced Acute Liver Injury by Tian, Xiangge et al.
        
Citation for published version:
Tian, X, Yan, F, Zheng, J, Cui, X, Feng, L, Li, S, Jin, L, James, TD & Ma, X 2019, 'Endoplasmic Reticulum
Targeting Ratiometric Fluorescent Probe for Carboxylesterase 2 Detection in Drug-Induced Acute Liver Injury',
Analytical Chemistry, vol. 91, no. 24, pp. 15840-15845. https://doi.org/10.1021/acs.analchem.9b04189
DOI:
10.1021/acs.analchem.9b04189
Publication date:
2019
Document Version
Peer reviewed version
Link to publication
This document is the Accepted Manuscript version of a Published Work that appeared in final form in Analytical
chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To
access the final edited and published work see https://pubs.acs.org/doi/abs/10.1021/acs.analchem.9b04189
University of Bath
Alternative formats
If you require this document in an alternative format, please contact:
openaccess@bath.ac.uk
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 17. Nov. 2020
1 
Endoplasmic Reticulum Targeting Ratiometric Fluorescent Probe for 
Carboxylesterase 2 Detection in Drug-induced Acute Liver Injury 
Xiangge Tian, 
†, # 
  Fei Yan, †, ‡, # Jingyuan Zheng, †, # Xiaolin Cui, † Lei Feng, †,* Sheng Li , † Lingling Jin , † 
Tony D. James §, * and Xiaochi Ma †, ‡, * 
† Academy of Integrative Medicine, National-Local Joint Engineering Research Center for Drug-Research and Development 
(R&D) of Neurodegenerative Diseases, College of Pharmacy, Dalian Medical University, Lvshun South Road No 9, Dalian 
116044, China; 
‡ Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, 
Xuzhou, 221004, Jiangsu, China; 
§ Department of Chemistry, University of Bath, Bath, BA2 7AY, UK.  
ABSTRACT: Carboxylesterase 2 (CES2) an endoplasmic reticulum (ER) located phase I enzyme plays a vital role in the metabolism 
of various endogenous and exogenous substances, and is regarded as an important target for the design of prodrugs. Unfortunately, 
superior highly selective ER targeting fluorescent probes for monitoring of CES2 are not currently available. Herein, we report an 
ER targeting CES2 selective and sensitive ratiometric fluorescent probe ERNB based on the ER localizing group p-
toluenesulfonamide. ERNB possessed high specificity, sensitivity, and exhibited excellent subcellular localization when compared 
with commercial ER tracker, and was used to image CES2 in the ER of living cells. Additionally, using ERNB we evaluated the 
CES2 regulation under DL-dithiothreitol and tunicamycin-induced ER stress. Furthermore, we determined the down regulation of 
CES2 activity and expression in the acetaminophen-induced acute liver injury model. Based on these results we conclude that ERNB 
is a promising tool for highlighting the role of CES2 in the ER and in exploring the role of CES2 in the development of diseases 
associated with ER stress.   
 
INTRODUCTION 
Carboxylesterase 2 (CES2) an important phase I metabolic 
enzyme plays a vital role in the metabolism of various 
endogenous substrates such as acyl-CoA, acylcarnitine, 
cholesterol ester etc., it is also responsible for the detoxification 
of clinical drugs, and can activate many prodrugs such as anti-
tumour drugs irinotecan (CPT-11) and capecitabin, narcotics 
(cocaine, heroin and meperidine) and methylphenidate.1-5 Thus, 
CES2 is regarded as a molecular target for prodrugs.5 
Furthermore, CES2 has been shown to be important in several 
critical diseases, for instance, CES2 can prevent liver steatosis 
by modulating lipolysis, endoplasmic reticulum (ER) stress; 
and reverse obesity-induced diacylglycerol accumulation and 
glucose intolerance.4 In mammals, CES2 locates in the ER and 
is expressed in several organs including liver, intestine, and 
kidney.6,7 Notably, the expression of CES2 shows inter-
individual variation in the clinic and can be regulated by several 
mechanisms, such as gene polymorphism and epigenetic 
processes. ER stress usually occurs during pathological states 
including liver injury, inflammation, obesity, drug-induced 
toxicity etc.,8-14 and has received wide attention due to its role 
in drug metabolism and human diseases.15-17 However, changes 
of CES2 located in the ER associated with stress, have not been 
fully evaluated. Therefore, it is of great importance to develop 
a sensitive and specific method for the real-time detection of 
endogenous endoplasmic reticulum CES2 for various disease 
diagnoses and therapies. 
Fluorescence imaging technology with its numerous 
advantages, such as good sensitivity, real-time detection, high 
spatiotemporal resolution, and non-invasive monitoring ability 
in living systems has been widely applied in various diseases 
diagnoses and therapies.18-26 Fluorescent probes for monitoring 
CES2 have been developed for tissues and cell preparations;27-
32 however, measuring CES2 in the ER during some ER- 
 
associated diseases has been limited, since none of the CES2 
fluorescent probes to date are ER targeting. 
Herein, we designed and developed an ER targeting 
ratiometric fluorescent probe (ERNB) for CES2 detection 
based on the substrate preferences of CES2. Targeting was 
achieved by introducing a well-known ER-targeting group p-
toluenesulfonamide (Scheme 1).33-36 ERNB exhibited high 
selectivity and sensitivity toward CES2 and could image 
endogenous CES2 in cells and tissues. Furthermore, ERNB 
displayed excellent ER-targeting ability and exhibited 
exceptional colocalization with commercial ER tracker. 
Additionally, ERNB indicated that the activity of CES2 was 
significantly reduced under DL-dithiothreitol (DTT) and 
tunicamycin-induced ER stress in an acute liver injury model. 
 
 
 
Scheme 1 The structure and mechanism of ER targeting 
fluorescent probe ERNB for the detection of CES2. 
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EXPERIMENTAL SECTION 
Materials and instruments. Different metabolic enzymes 
including: Carboxylesterases (CES1, CES2), β-galactosidase 
(β-Gla), Lysozyme (Ls), Carbonic anhydrase (Cas), β-
glucuronidase (β-Glu), β-glucosidase (β-Glc) and Human 
serum albumin (HSA) were purched from Sigma-Aldrich (St 
Louis, MO). L (+)-Cysteine, Myristic acid, Tryptophan, 
Tyrosine, Serine, Glutanic acid, Glutathione, Glycine, Lysine, 
L-Arginine, Glutamine, and Glucose were all purchased from 
Shanghai yuanye (Shanghai, China). ER-tracker Red (BODIPY
Ⓡ  TR Glibenclamide) is purchased from Shanghai Yisheng 
(Shanghai, China). HepG2 cells were purchased from American 
Type Culture Collection (Manassas, VA). HepG2 cells were 
purchased from American Type Culture Collection (Manassas, 
VA). CES2 and β-actin antibodies were obtained from Abcam. 
All fluorescence tests performed on Synergy H1 Hybrid Multi-
Mode Microplate Reader (BioTek). NMR spectra were 
obtained using Bruker Avance II (400 MHz) spectrometer. 
Accurate mass detection was measured on G6224A TOF MS. 
The HPLC analysis was conducted on the Waters e2695 
equipped with 2998 PDA Detector. All other reagents and 
solvents used were of the highest grade commercially available.  
Synthesis pathway for ERNB 
Synthesis of ERNH. 4-hydroxy-1, 8-naphthalic anhydride 
(107.0 mg, 0.50 mmol) and N-tosylethylenediamine (117.7 mg, 
0.55 mmol) were dissolved in ethanol (30 mL). The reaction 
mixture was stirred and refluxed for 24 h. After cooling to room 
temperature, the solvent was removed in vacuo, and the residual 
solid was purified by 2767 Waters Prominence HPLC system 
equipped with a Waters 2767 sample manager, and a Waters 
2545 binary Gradient Module, a Waters 2489 UV/Visible 
Detector and a  Waters X Bridge C18 (19 mm × 150 mm, 5 μm) 
chromatograph column. The preparative liquid phase: mobile 
phase contained A (100% methanol) and B (Trifluoroacetic acid 
water containing 10% methanol), the elution process was 
Isometric elution and the mobile phase was 60% (A): 40% (B).) 
Affording ERNH 49.2 mg. (Yield 24%). 1H NMR (400 MHz, 
DMSO-d6) δ 11.86 (s, 1H), 8.54 (d, J = 8.3 Hz, 1H), 8.44 (d, J 
= 7.3 Hz, 1H), 8.32 (d, J = 8.2 Hz, 1H), 7.74 (dt, J = 12.3, 7.0 
Hz, 2H), 7.59 (d, J = 7.5 Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H), 7.16 
(d, J = 8.2 Hz, 1H), 4.09 (t, J = 6.4 Hz, 2H), 3.06 (q, J = 6.3 Hz, 
2H), 2.26 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ 164.26, 
163.55, 160.70, 142.87, 138.10, 133.98, 131.55, 129.91, 129.79, 
129.33, 126.82, 126.05, 122.84, 122.37, 113.17, 110.36, 40.63, 
39.46, 21.33. HRMS (ESI negative) calcd for [M-H]– 409.0864, 
found 409.0871. (Figure S1-S5). 
Synthesis of ERNB. To a solution of ERNH (41 mg, 0.10 mmol) 
and Et3N (28 μL, 0.20 mmol) in 10 mL of DMF, benzoyl 
chloride (18 μL, 0.15 mmol, mixed with 1 mL of DMF) was 
added dropwise at 0 °C over 15 min. After stirring at this 
temperature for 1 h, the mixture was warmed to room 
temperature and stirred overnight. The solvent was removed, 
and the residual solid was purified by preparative HPLC as 
mentioned above and the isometric mobile phase was set with 
70% (A): 30% (B). Affording ERNB 22.6 mg. (Yield 44%). 1H 
NMR (400 MHz, DMSO-d6) δ 8.54 (t, J = 7.6 Hz, 2H), 8.41 (d, 
J = 8.4 Hz, 1H), 8.31 (d, J = 7.8 Hz, 2H), 7.88 (dt, J = 15.8, 7.7 
Hz, 3H), 7.77 (t, J = 6.2 Hz, 1H), 7.70 (t, J = 7.5 Hz, 2H), 7.59 
(d, J = 7.6 Hz, 2H), 7.24 (d, J = 7.8 Hz, 2H), 4.14 (t, J = 6.3 Hz, 
2H), 3.12 (dd, J = 12.6, 6.3 Hz, 2H), 2.27 (s, 3H). 13C NMR 
(100 MHz, DMSO-d6) δ 164.73, 163.87, 163.36, 151.81, 142.95, 
138.12, 135.14, 131.73, 131.68, 130.70, 129.95, 129.70, 129.18, 
128.58, 128.41, 128.28, 126.82, 125.37, 123.09, 120.83, 120.70. 
40.44, 39.84, 21.34. HRMS (ESI positive) calcd for [M+H]+ 
515.1271, found 515.1276. All the data were displayed in 
Figure S6-S9. 
The fluorescence response of ERNB toward CES2. The 
fluorescence characteritics of ERNB toward CES2 were 
evaluated using our stander incubation system. Briefly, the in 
vitro assay system  was performed in 100 mM potassium 
phosphate buffer (pH 7.4), with a final incubation volume of 0.2 
mL. Firstly, potassium phosphate buffer, CES2  (the final 
concentration was 0.1 mg/mL) and 2 μL of the probe ERNB 
(the final concentration was 20 μM) was mixed, in order to 
avoid interference with the enzymes’ catalytic activity the final 
concentration of DMSO did not exceed 1 % (v/v). Next, the 
sample was incubated at. 37 °C for 1 h, then, the reaction was 
terminated by the addition of 100 μL of acetonitrile and 
centrifged for 10 min at 4 °C with a centrifugal force of 20,000 
× g. Then, the supernatant was used for fluorescence and HPLC 
analysis, respectively. Notably, control incubations without 
enzyme were performed in order to ensure that reaction was 
enzyme-dependent. For HPLC analysis we used the following 
method: the mobile phase consisted of methanol (A) and 0.03% 
trifluoroacetic acid water (B) at a flow rate of 0.8 mL/min. The 
following gradient conditions were used: 0 – 5 min 40% B; 5 – 
15 min 40% – 15% B; 15 – 20 min 15% – 10% B; 20 – 25 min 
10% – 40% B. 
Selectivity of ERNB toward CES2. In order to confirm the 
selectity and stability of ERNB, ERNB was incubated with 
different hydrolases including: Ls, Cas, CES1, CES2, β-GLa, 
β-Glc, β-Glu and HSA in our standard incubation system, 
respectively. The final concentrations of all hydrolases were 8 
μg/mL. Additionally, the fluorescence stability of ERNB with 
various exogenous substrates (Myristic acid, Serine, Tyrosine, 
Tryptophan, Glutamic acid, L-Arginine, Glycine, Glutamine, 
L(+)-Cysteine, Lysine, Glucose and Glutathione) as well as 
some common ions (Ni2+, Mn2+, Mg2+, Ca2+, Zn2+, K+, Sn4+, 
Cu2+, Na+ , Fe3+, SO4
2-, CO3
2-, Ba2+ and NO3
-) were also 
evaluated, the final concentration of ERNB was 20 μM, all 
assays were conducted at 37 °C for 1 h. Then the data was 
analyzed using the Prism software package (GraphPad 
Software 7.0, LaJolla, CA). 
Chemical inhibition and kinetic study. The Chemical 
inhibition was also performed in order to confirm the selectivity 
of ERNB for CES2, briefly, diffiient inhibitors Bis-p-
nitrophenyl phosphate (BNPP, general inhibitor for CESs), 
Loperamide (LPA, CES2 selective inhibitor), Phenylbutazone 
(UGTs inhibitors), α-galactose (general inhibitor for 
glycosidases) were added in our incubation system with ERNB, 
respectively. Then, the residual activity was caculated by 
comparing with the control grop added DMSO. Furthermore, 
the kinetic of ERNB for CES2 over a concentration range from 
0 – 180 μM was performed and the kinetic parameters were 
obtained. 
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The fluorescence imaging of CES2 in living cells. After the in 
vitro assay, the application of ERNB for fluorescence imaging 
was also evaluated. HepG2 cells  were cultured in a DME/F-12 
medium with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) 
antibiotics (penicillin/streptomycin) at 37 °C with 5% CO2. At 
first, the cytotoxicity of ERNB was evaluated by the CCK-8 
assay (Roche Diag-nosis, Indianapolis, IN). Briefly, HepG2 
cells were seeded in a 96-well plate at a concentration of 8 × 103 
/mL in culture medium and incubated overnight for attachment. 
Then different concentrations of ERNB (0, 1, 2, 5, 10, 20, 50, 
100 μM) which was dissolved in FBS free culture medium was 
added to the 96-well plate, respectively. After 24 hours 
incubation, the culture medium was discarded and FBS free 
culture medium with 10% (v/v) CCK-8 was added for another 
one hour incubation in an incubator, and then detected at 450 
nm using the Synergy H1 Reader (Bio-Tek). Then the cell 
viability was calculated and the group in the absence of ERNB 
was considered as 100%. 
For the fluorescence imaging, briefly, HepG2 cells were seeded 
on 20-mm glass polylysine-coated confocal cell culture dishes 
and attached overnight. Next day, after discarding the culture 
medium, a medium containing 80 μM of ERNB was added to 
the cluture cells and incubated at 37 °C for 1 h. In addition a 
control group with the same volume of blank solvent. After the 
incubation, the cells were washed with 37 °C PBS (pH 7.4) 
three times. Then cells were imaged using a confocal 
microscope (Leica TCS SP8) with an excitation wavelength at 
405 nm and the fluorescence signal in the blue channel (425 – 
475 nm) and green channel (535 – 585 nm) were recorded, 
respectively. Then, the imaging ratio was calculated from 
green/blue. Simultaneously, the CES2 selective inhibitor LPA 
(50 μM) was pre-treated for 30 min and then ERNB was added 
for chemical inhibition in living cells. The purpose was to 
confirm that the fluorescence signal was generated by CES2 in 
HepG2 cells. 
The fluorescence imaging in tissues by ERNB. In view of the 
good imaging characteritics of ERNB, we applyed ERNB for 
tissue fluorescence imaging. In detail, 10 μm frozen tissue slices 
were prepared from the cancer tissues of HepG2 bearing nude 
mice. All protocols for this animal study conformed to the 
Guide for the Care and Use of Laboratory Animals. All animal 
experiments were performed in accordance with guidelines 
approved by the ethics committee of Dalian Medical University 
(the protocol registry number: AEE17030). The slices were 
incubated with ERNB (50 μM) at 37 °C for 1 h followed by 
washing the slices three times with PBS. Subsequently, the 
stained samples with ERNB were examined with a Leica TCS 
SP8 confocal microscope the conditions were the same as those 
used cell imaging. 
Co-localization Imaging in Living Cells. The co-localization 
imaging in HepG2 cells was performed to explore whether 
ERNB could target the endoplasmic reticulum, due to the probe 
ERNB generating a significant increase in the green channel, 
we stained the ER using a commicial tracker Red (BODIPY
Ⓡ
 
TR Glibenclamide). The staining procedures were performed 
following the instructions of the tracker and the ERNB was just 
added as above. Additionally, mitochondrial and lysosome 
tracker were also added, respectively. Then, the cells were 
imaged by the laser confocal microscope. 
The CES2 changes under ER Stress. At first, after the 
attachment of HepG2 cells overnight the classic ER stress 
inducer DTT (5 mM) and tunicamycin (20 μg/mL) was added 
into the cells and incubated for 60 min and 5 h, respectively. 
Then, ERNB was added into the cells and incubated for another 
1 hour. Then, the cells were imaged using a confocal 
microscope (Leica TCS SP8) with an excitation wavelength of 
405 nm and different fluorescence channel signals were 
collected as previously described. Using the above experiments, 
our aim is to illustrate the change of CES2 activity at the ER 
under ER stress and give some useful guidance for the diagnosis 
and therapy of diseases involved in ER stress. 
The CES2 regulation in a drug-induced acute liver injury 
model. We estabilished a drug-induced acute liver injury model 
using APAP (acetaminophen) at a dose of 400 mg/kg; briefly, 
male C57BL/6J mice were randomly separated into the 
following two groups: control (saline, ip); APAP only (400 
mg/kg, ip); they were executed after being treated with APAP 
(400 mg/kg) for 12 h, the serum and liver tissues were obtained 
for the biochemical analysis Alanine aminotransferase (ALT) 
and Aspartate aminotransferase (AST) and pathological 
examination (H & E staining). All protocols for this animal 
study conformed to the Guide for the Care and Use of 
Laboratory Animals. All animal experiments were performed in 
accordance with guidelines approved by the ethics committee 
of Dalian Medical University (the protocol registry number: 
AEE17030). Additionally, the frozen liver slices were prepared 
and imaged using ERNB to observe the activity change of 
CES2 in ER stress animal model, the procedures were as 
described above for tissue imaging. Furthermore, the change of 
the CES2 expression was also assayed using western blot. 
RESULTS AND DISCUSSIONS 
Spectroscopic change of ERNB toward CES2. Firstly, the 
absorption and fluorescence properties of ERNB toward CES2 
were investigated. As shown in Figure 1 A-B, ERNB displayed 
a maximum absorption at 350 nm, and a new absorption peak 
at 450 nm was observed after incubation with CES2, the same 
results were also observed for the substrate ERNB and 
metabolite ERNH (Figure S10). In addition the fluorescence 
intensity at 560 nm increased along with a decrease in 
fluorescence intensity at 414 nm, HPLC analysis indicated that 
CES2 catalyzed the hydrolysis of ERNB to ERNH (Figure 
S11). We then observed the fluorescence changes of ERNB 
toward CES2 at different protein concentration, as shown in 
Figure 1 C-D, the fluorescence intensity ratio I560/I414 exhibited 
good linearity over a range of CES2 concentrations (0 – 8 
μg/mL). These results indicate that ERNB can be used to 
monitor CES2 activity in complex bio-samples. 
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Figure 1 The absorption (A) and emission (B) spectral response 
of ERNB (20 μM) toward CES2; (C, D) linear response of 
ERNB toward different concentration of CES2 over a range 
from 0 – 8 μg/mL. λex = 380 nm. 
Selectivity of ERNB. The selectivity of ERNB toward CES2 
was evaluated, as shown in Figure 2 A, after incubation with 
different hydrolases including Ls, β-Glc, Cas, CES1, CES2, 
HSA, β-Gla, β-Glu, only CES2 could trigger the hydrolysis 
reaction, and the catalytic activity was much higher than CES1. 
Furthermore, ERNB showed good stability toward common 
endogenous substrates and metal ions including Ser, Glu, Trp, 
Cys, Arg, Cys, Lys, Gly, Gln, myristic acid, GSH, Glucose, 
Ca2+, Mg2+, Mn2+, Ni2+, Sn4+, K+, Cu2+, Zn2+, Na+, Fe3+, CO3
2-, 
NO3- and Ba2+, facilitating the use of ERNB in living systems 
(Figure 2 B). Additionally, during the chemical assay only CES 
general inhibitor bis-p-nitrophenyl phosphate (BNPP) and 
CES2 selective inhibitor loperamide (LPA) could significantly 
inhibit the reaction in HLM, which further suggested that 
ERNB hydrolysis was selectively catalyzed by CES2, (Figure 
2 C). The result was consistent with the substrate preferences 
of CES2 that it mainly recognizes substrates with large alcohol 
and small acyl group, such as irinotecan. Good kinetic behavior 
with enzymes is vital for activity-based fluorescent probes. 
Figure 2D indicates that ERNB follows a classic Michaelis-
Menton kinetic model with CES2, the kinetic parameters Km 
and Vmax are 3.48 ± 0.61 μM and 0.027 ± 0.001 nmol/min/μg, 
respectively. Km is equal to the substrate concentration at which 
the reaction rate is half its maximal value, thus, our results 
indicate that ERNB has high selectivity and affinity toward 
CES2, excellent kinetic performance, making ERNB a suitable 
tool for quantifying CES2 activity in complex biological 
samples. 
Fluorescence imaging of CES2 in living cells and tissues. We 
then explored the use of ERNB for imaging endogenous CES2 
in living cells and tissues. Firstly, the CCK8 assay indicated that 
ERNB was not cytotoxic up to 100 μM (Figure S12). Secondly, 
in Figure 3, after incubation with ERNB for 1 h, a fluorescence 
signal at 425 – 475 nm was observed clearly indicating that 
ERNB could cross the cell membrane smoothly; a new 
fluorescence signal at 535 – 585 nm was detected, and the ratio 
(green/blue) was calculated to be 2.4 which indicated that CES2 
expressed in HepG2 cells and mediated the generation of a 
fluorescence signal in the green 
 
Figure 2. (A) The selectivity of ERNB amongst various 
hydrolases; (B) the stability of ERNB towards diffident amino 
acids and metal ions; (C) the chemical inhibition of different 
selective inhibitors towards ERNB reaction in HLM (Human 
liver microsome) system; (D) kinetic model of ERNB with 
CES2. 
channel, while control HepG2 cells produced no fluorescence 
signal under the same conditions (Figure S13). Additionally, 
HepG2 cells pre-incubated with the CES2 inhibitor LPA (50 
μM) displayed reduced fluorescence intensity in the green 
channel and the fluorescence intensity ratio decreased to 0.88, 
these results indicated that the fluorescence signal was 
dependent on intracellular CES2 expression. Additionally, the 
expression of CES2 in tumor tissues prepared from the cancer 
tissues of HepG2 bearing nude mice was also investigated. As 
shown in Figure S14, significant fluorescence in the blue and 
green channels was detected in HepG2 tissues, and high ratio 
values indicating an abundant expression of CES2 in HepG2 
cells.  
Co-localization imaging of CES2 by ERNB. After the 
systematic assay of ERNB including response, selectivity, 
linear range, stability and imaging in living cells, we further 
explored the subcellular localization of CES2 in living cells. As 
shown in Figure 4, HepG2 cells were co-incubated with  
 
Figure 3. (A，B) The fluorescence imaging of CES2 in HepG2 
cells at different channel (Blue: 425 – 475 nm; Green: 535 – 
585 nm) after incubation with ERNB (100 μM); (E, F) the 
HepG2 cell preincubated with CES2 selective inhibitor LPA 
(50 μM); (C, G) the bright field images of HepG2 cells; (D, H) 
Fgreen/Fblue intensity ratios. Scale bars 50 μm. 
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Figure 4. (A) Fluorescence images of of ERNB in HepG2 at 
the blue channel (425 – 475 nm); (B)  fluorescence images of 
of ERNB in HepG2 at the green channel (535 – 585 nm); (C) 
ER-Tracker (red); (D) merged fluorescence image of the green 
channel and ER-Tracker channel (red); (E) intensity scatter plot; 
(F) fluorescence intensity for region of interest (white line in 
panel D). Scale bars 10 μm. 
ERNB and commercial ER-Tracker (Red) then imaged using a 
confocal fluorescence microscope. As expected, the 
fluorescence overlapped (Figure 4D) and the green 
fluorescence signal produced by ERNB correlated well with the 
commercial ER-Tracker red signal and the Pearson’s 
correlation was calculated to be 0.96. Additionally, ERNB 
displayed almost no fluorescence inside the mitochondria 
(Figure S15) and lysosome (Figure S16), respectively. All 
these results indicated that ERNB could image endogenous 
CES2 in living systems and exclusively target the ER which is 
useful for the evaluation of CES2 changes and regulation under 
ER stress and some ER-related diseases. 
CES2 regulation under ER Stress. ER stress is a common 
condition for diseases such as diabetes, neurodegenerative 
disease, ischemia/reperfusion injury, hypoxia, and drug-
induced toxicology which can result in cell death. CES2 is a 
major phase I metabolic enzyme which is mainly expressed at 
the ER. Importantly, in our work, the activity changes of CES2 
under ER stress could be evaluated using ERNB. As shown in 
Figure 5, after treatment with DTT (DL-dithiothreitol, an 
acknowledged ER stress inducer),37,38 the CES2 activity 
exhibited a sharp decrease which was reflected by a reduced 
fluorescence intensity ratio compared to the control group (0.79 
vs 2.34). The same effect was observed in the tunicamycin-
induced ER stress system (Figure S17).39,40  All these results 
indicated that the activity of CES2 was reduced under ER stress. 
Detection of CES2 in APAP-induced acute liver injury model 
In order to further confirm the variation of CES2 activity under 
ER stress, an acetaminophen (APAP)-induced acute liver injury 
model was established which was accompanied by ER stress.41-
44 As shown in Figure 6 A-D, after treatment with APAP 400 
mg/kg for 12 h, the liver surface was rough with many hepatic 
parenchymal injury areas, and the index of liver function 
enzyme ALT displayed a 23-fold increase, as well as 3-fold 
increase of AST, all these results indicate that an acute liver 
injury model has been established, additionally, the large area 
tissue necrosis in the H & E staining confirmed liver injury 
(Figure S18). Subsequently, frozen tissue slices of the  
 
Figure 5. (A, B) The fluorescence imaging of HepG2 cells after 
incubation with ERNB; (E, F) the imaging of CES2 after 
treatment with DTT (5 mM) for 1 h; (C, G) the bright field of 
HepG2 cells; (D, H) Fgreen/Fblue intensity ratios. Scale bar is 50 
μm. 
liver were prepared from the APAP treated and control groups 
respectively, and then incubated with ERNB (50 μM) for 1 h. 
As shown in Figure 6 E – J, the APAP treated group gave a 
very weak fluorescence signal in the green channel and lower 
ratio values compared with the control. These results further 
confirmed the decrease of CES2 activity in drug-induced acute 
liver injury. Additionally, a western blot assay indicated a 
down-regulation of CES2 activity under ER stress which was 
consistent with the imaging results using ERNB (Figure 6 K). 
 
Figure 6. The bright field of liver of normal (A) and APAP-
induced group (B); (C) the serum ALT assay for normal and 
APAP-treatment group; (D) the serum AST assay for normal 
and APAP treatment group; (E, F) fluorescence imaging of 
CES2 in normal liver tissue; (H, I) CES2 imaging in APAP-
induced acute liver injury tissue; (G, J) Fgreen/Fblue intensity 
ratios; (K) Western blot assay of CES2 in normal and APAP-
induced liver. 
CONCLUSIONS 
In summary, in order to monitor CES2 activity under ER stress, 
we developed a novel stable ER-targeting ratiometric 
fluorescent probe named ERNB with high selectivity and 
sensitivity for application in vitro and in living systems. The 
fluorescence intensity ratio (I560/I414) displayed excellent 
dependence on CES2 activity. In addition, ERNB was used for 
real-time evaluation of endogenous CES2 changes under ER 
stress in living HepG2 cells and drug-induced acute liver injury 
6 
models. Our results indicate a significant decrease in CES2 
activity and expression under ER stress. Therefore, ERNB can 
serve as a useful tool for elucidating the role of CES2 in the ER 
and can be used to follow the bio-functions of ER stress 
associated diseases. 
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